Technical Description
The invention involves a biocompatible, anti-angiogenic polymeric formulation for breast cancer management, featuring a cost-effective synthesis.
Problems Addressed
- Lack of Biocompatibility
- Heat Sensitive Release
- Toxic Cellular Environment
- pH-sensitive Instability
Tech Features
- Monodispersed Particles
- Apoptotic Therapy
- High Thermal Stability
- pH-dependent Drug Release
- Reduced Cellular Toxicity
Target Audience
- Cancer Care Centres
- Pharmaceutical Industry
- Healthcare Sector
- Research & Development
Tech ID: P35-1937 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
